Similarly, we also found that high m6A-risk level can suppress the activity of Type II IFN response (Figure7B), which suggested that HNRNPC may also promote ACC progression via regulating the IFN response. The gene discussed is IFNA1; the disease is adrenal cortex carcinoma.